Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.21.2
CONDENSED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 3,191,581  
Prepaid expenses and other current assets 565,282  
Total Current Assets 3,756,863  
Deferred offering costs   $ 197,790
Investments held in Trust Account 345,055,724  
TOTAL ASSETS 348,812,587 197,790
Current liabilities    
Accrued expenses 1,320,800 6,093
Accrued offering costs 12,000 120,540
Promissory note - related party   52,250
Total Current Liabilities 1,332,800 178,883
Warrant liabilities 19,107,000  
Deferred underwriting fee payable 12,075,000  
Total Liabilities 32,514,800 178,883
Commitments and contingencies
Shareholders' (Deficit) Equity    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital   24,137
Accumulated deficit (28,703,076) (6,093)
Total Shareholders' (Deficit) Equity (28,702,213) 18,907
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY 348,812,587 197,790
Class A Ordinary shares subject to possible redemption    
Current liabilities    
Class A ordinary shares subject to possible redemption 34,500,000 and no shares at $10.00 per share redemption value as of September 30, 2021 and December 31, 2020, respectively 345,000,000  
Class B Ordinary shares    
Shareholders' (Deficit) Equity    
Common stock $ 863 $ 863